|Articles|June 8, 2020
Managing the COVID-19 Drug Safety Response
Author(s)MyMeds&Me
Current safety reporting systems cannot meet the demands of a COVID-19 response. Find out how digital transformation enables rapid understanding & management of drug safety.
Trending on PharmExec
1
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
2
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms
3
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
4
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
5